<p>Novel Corona virus-2 (Covid-19) is spreading and
causing major damage around the globe and constantly increasing daily. There is
a prerequisite of expeditious development of safe and efficient drugs for such
a contagious disease. In this regard, utilization of a computational approach
with an aim to provide potential enzyme inhibitors derived from natural
resources will give a providential therapy. The present study investigated one
of the promising plants namely Glycyrrhiza glabra L. It has various medicinal
properties viz. anti-inflammatory, anti-cancer, anti-demulcent, expectorant,
etc. <i>In-Silico</i> Analysis of liquiritin
against SARS-CoV-2 Mpro was carried out using Autodock 4.2.6 and results were
compared with presently prescribed drugs i.e. dexamethasone, remdesivir,
hydroxychloroquine, and azithromycin. The binding energy of liquiritin was
found to be -6.62 kcal/mol. It shows presence of hydrogen bond, hydrophobic
interaction and electrostatic interaction with six active residues THR26,
GLY143, CYS145, HIS 164, GLU166, and GLN189. Comparative studies investigated
that dexamethasone, remdesivir, hydroxychloroquine, and azithromycin have four
(THR26, GLY143, CYS145, GLU166), three (CYS145, GLU166, GLN189), four (GLY143,
CYS145, HIS 164, GLN189) and two (GLU166, GLN189) identical active residues,
respectively. The present study recommended liquiritin as a potential candidate
against SARS-CoV-2 as it is naturally derived and has tremendous traditional
usage against various diseases. However, in-vitro and in-vivo studies are
required to prove its efficacy.</p>